These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19756620)

  • 1. [Immunocytochemical identification of carcinomas of unknown primaries on fine-needle-aspiration-biopsies].
    Böcking A; Pomjansky N; Buckstegge B; Onofre A
    Pathologe; 2009 Dec; 30 Suppl 2():158-60. PubMed ID: 19756620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
    Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
    Maguire B; Whitaker D; Carrello S; Spagnolo D
    Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.
    Hiensch R; Meinhof K; Leytin A; Hagopian G; Szemraj E; Epelbaum O
    Clin Respir J; 2017 Nov; 11(6):1086-1090. PubMed ID: 26646473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry.
    Alberti N; Serrano-Egea A; García-García E; Ballestín C; Pérez-Barrios A; López-Ríos F; de Agustín P
    Acta Cytol; 2007; 51(2):203-6. PubMed ID: 17425204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic role of BAP1 in serous effusions.
    Davidson B; Tötsch M; Wohlschlaeger J; Hager T; Pinamonti M
    Hum Pathol; 2018 Sep; 79():122-126. PubMed ID: 29802871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
    Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
    Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
    Lung; 1995; 173(2):79-87. PubMed ID: 7536281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration.
    Cimbaluk D; Kasuganti D; Kluskens L; Reddy V; Gattuso P
    Diagn Cytopathol; 2006 Jan; 34(1):33-6. PubMed ID: 16355399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult granulosa cell tumor presenting as metastases to the pleural and peritoneal cavity.
    Gupta N; Rajwanshi A; Dey P; Suri V
    Diagn Cytopathol; 2012 Oct; 40(10):912-5. PubMed ID: 21618710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
    Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
    Davidson B; Stavnes HT; Hellesylt E; Hager T; Zeppa P; Pinamonti M; Wohlschlaeger J
    Hum Pathol; 2016 Jan; 47(1):104-8. PubMed ID: 26520416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.